Taken together, this data demonstrates the presence of bioactive mediators in the bowel of patients with PI-IBS, which have the potential to directly activate colonic afferents and sensitize TRPV1 channels, potentially contributing to VHS in PI-IBS. This evidence concerns the gene TRPV1 and irritable bowel syndrome.